Fund comparison · from official SEC filings

JAGLX vs PRHSX: how much do they overlap?

Janus Henderson Global Life Sciences Fund and T. Rowe Price Health Sciences Fund, Inc.
Holdings overlap
49%
of assets, by weight
Shared positions
46
of 98 / 287 holdings
JAGLX expense ratio
0.92%
net, per year
PRHSX expense ratio
0.83%
net, per year
Shared holdings
Company
JAGLX
PRHSX
L
LLYELI LILLY & CO
8.85%
10.14%
J
JNJJOHNSON & JOHNSON
7.30%
2.44%
A
AZNASTRAZENECA PLC
4.60%
3.17%
T
TMOTHERMO FISHER SCIENTIFIC INC
2.51%
4.07%
A
ABBVABBVIE INC
4.06%
2.84%
I
ISRGINTUITIVE SURGICAL INC
2.02%
3.65%
S
SYKSTRYKER CORP
1.65%
3.46%
M
MRKMERCK & CO. INC.
1.48%
3.44%
U
UNHUNITEDHEALTH GROUP INC
3.14%
3.09%
A
ARGXARGENX SE - ADR
2.40%
2.92%
R
REGNREGENERON PHARMACEUTICALS
0.36%
2.65%
G
GILDGILEAD SCIENCES INC
1.27%
2.60%
P
PRAXPRAXIS PRECISION MEDICINES I
2.45%
0.56%
V
VRTXVERTEX PHARMACEUTICALS INC
2.06%
2.43%
B
BBIOBRIDGEBIO PHARMA INC
2.22%
0.59%
D
DHRDANAHER CORP
1.64%
2.05%
R
RVMDREVOLUTION MEDICINES INC
2.04%
1.36%
H
HCAHCA HEALTHCARE INC
1.88%
0.90%
B
BSXBOSTON SCIENTIFIC CORP
1.84%
0.92%
A
AMGNAMGEN INC
1.83%
0.98%
A
ALNYALNYLAM PHARMACEUTICALS INC
0.29%
1.62%
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.51%
0.36%
C
CVSCVS HEALTH CORP
1.48%
0.86%
M
MIRMMIRUM PHARMACEUTICALS INC
1.44%
0.19%
U
UTHRUNITED THERAPEUTICS CORP
1.33%
1.34%
Only in JAGLX
N
NVSNOVARTIS AG-SPONSORED ADR
2.86%
A
ABTABBOTT LABORATORIES
2.40%
R
RHHVFROCHE HOLDING AG
2.21%
S
SNYNFSANOFI
2.08%
A
ASND 2.25 04.01.28ASCENDIS PHARMA A/S
1.65%
P
PTCTPTC THERAPEUTICS INC
1.34%
G
GMEDGLOBUS MEDICAL INC - A
1.24%
T
TEVATEVA PHARMACEUTICAL-SP ADR
1.18%
M
MDTMEDTRONIC PLC
0.97%
D
DYNDYNE THERAPEUTICS INC
0.88%
T
TVTXTRAVERE THERAPEUTICS INC
0.82%
M
MDLNMEDLINE INC-CL A
0.74%
D
DXCMDEXCOM INC
0.68%
6
6XCSOLENO THERAPEUTICS INC
0.64%
U
UCBJFUCB SA
0.61%
B
BDXBECTON DICKINSON AND CO
0.55%
G
GKOSGLAUKOS CORP
0.55%
P
PENPENUMBRA INC
0.47%
E
EWTXEDGEWISE THERAPEUTICS INC
0.40%
X
XENEXENON PHARMACEUTICALS INC
0.39%
?
Janus Henderson Cash Liquidity Fund LLC
0.39%
C
COOCOOPER COS INC/THE
0.39%
D
DSKYFDAIICHI SANKYO CO LTD
0.36%
S
STESTERIS PLC
0.35%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.35%
Only in PRHSX
?
ASCENDIS PHARMA A/S - ADR
1.42%
B
BEIGFBEONE MEDICINES LTD-H
1.19%
R
ROIVROIVANT SCIENCES LTD
1.13%
I
INSMINSMED INC
1.06%
S
SMMTSUMMIT THERAPEUTICS INC
1.04%
N
NTRANATERA INC
1.03%
T
THCTENET HEALTHCARE CORP
1.01%
B
BTSGBRIGHTSPRING HEALTH SERVICES
0.98%
G
GHGUARDANT HEALTH INC
0.90%
K
KYMRKYMERA THERAPEUTICS INC
0.77%
C
CITHE CIGNA GROUP
0.74%
C
CGONCG ONCOLOGY INC
0.69%
C
CAHCARDINAL HEALTH INC
0.68%
K
KRYSKRYSTAL BIOTECH INC
0.65%
I
IONSIONIS PHARMACEUTICALS INC
0.61%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
0.58%
C
CELCCELCUITY INC
0.56%
R
RPRXROYALTY PHARMA PLC- CL A
0.55%
2
260CENTESSA PHARMACEUTICALS-ADR
0.50%
V
VERAVERA THERAPEUTICS INC
0.46%
5
5AXNUVALENT INC-A
0.43%
A
ABVXABIVAX SA-ADR
0.42%
C
CYTKCYTOKINETICS INC
0.40%
I
INCYINCYTE CORP
0.40%
S
SYRESPYRE THERAPEUTICS INC
0.40%
Hold JAGLX and PRHSX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.
JAGLX vs PRHSX: 49% holdings overlap — Unwrap.Fund